Future Treatment Choices Could Be Guided By Genes Linked To Breast Cancer Drug Resist
Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs...